-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704.O2.6 704. Cellular Immunotherapies: Cellular Therapies for ALL

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Lymphoid Leukemias, ALL, Hodgkin Lymphoma, Biological, Lymphomas, Non-Hodgkin Lymphoma, Clinical Research, B Cell Lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Clinically Relevant, Diseases, Aggressive Lymphoma, Therapies, Lymphoid Malignancies
Sunday, December 12, 2021: 12:00 PM-1:30 PM
B401-B402, Level 4, Building B (Georgia World Congress Center)
Moderators:
Saar Gill, MD, PhD, University of Pennsylvania and Martina Pennisi, MD, Fondazione IRCCS Istituto Nazionale dei Tumori
Disclosures:
Gill: Novartis: Other: licensed intellectual property, Research Funding; Carisma Therapeutics: Current holder of stock options in a privately-held company, Research Funding; Interius Biotherapeutics: Current holder of stock options in a privately-held company, Research Funding. Pennisi: Gilead Sciences: Consultancy.
12:00 PM

Noelle V Frey, MD, MS1, Saar Gill, MD, PhD1, Wei-Ting Hwang, PhD2*, Selina M. Luger, MD, FRCPC1, Mary Ellen Martin, MD1, Shannon R. McCurdy, MD1, Alison W. Loren, MD3, Keith W. Pratz, MD1, Alexander E. Perl, MD1, Julie Barber-Rotenberg, PhD4*, Amy Marshall4*, Marco Ruella, MD4, Simon F Lacey, PhD4, Joseph Fraietta, PhD4*, Andrew Fesnak, MD5*, Megan O'brien4*, Theresa Schanne4*, Jennifer L Brogdon, PhD6*, Boris Engels, PhD6*, Bruce L Levine, PhD4, Carl H June, MD7, David L Porter, MD1 and Elizabeth O. Hexner, MD1

1Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
2Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
3Cellular Therapy and Transplantation, Perelman Center for Advanced Medicine, Philadelphia, PA
4Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
5Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia
6Novartis Institutes for BioMedical Research, Cambridge, MA
7Center for Cellular Immunotherapies (CCI), The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

12:15 PM

Colleen Annesley, MD1, Corinne Summers, MD2,3, Michael A. Pulsipher, MD4, Jodi L. Skiles, MD5*, Amanda M. Li, MD6*, Anant Vatsayan, MD7*, Catherine Lindgren8*, Stephanie Mgebroff8*, Ashley Wilson, PhD8*, Wenjun Huang8*, Qian Vicky Wu9*, Josh Gustafson, PhD10*, Christopher Brown8*, Michael C. Jensen, MD11*, Julie R. Park, MD12* and Rebecca A Gardner, MD1

1Division of Hematology-Oncology, Seattle Children's Hospital, Seattle, WA
2Seattle Children's Hospital, Seattle, WA
3Fred Hutchinson Cancer Research Center, Seattle, WA
4Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA
5Riley Hospital for Children, Indianapolis, IN
6Div. of Hematology, Oncology, and BMT, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada
7CNMC, Washington, DC
8Seattle Children's Research Institute, Seattle, WA
9Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
10Seattle Children's Research Institute, Seattle
11Seattle Children's Therapeutics, Seattle Children's Research Institute, Seattle, WA
12Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA

12:30 PM

Swati Naik, MBBS1, Spyridoula Vasileiou, PhD1*, Ifigeneia Tzannou, MD1*, Manik Kuvalekar, Msc1*, Ayumi Watanabe, Bsc1*, Catherine Robertson1*, Adrian P. Gee, PhD1, Bambi J. Grilley, RPh1*, George Carrum, MD2, Rammurti Kamble, MD2, LaQuisa C. Hill, MD1, Robert A. Krance, MD1,3, Caridad A. Martinez1*, Bilal Omer, MD1, Stephen Gottschalk, MD4, Helen E. Heslop, MD, DSc1, Cliona M. Rooney, PhD1*, Juan Vera, MD1*, Ann Leen, PhD1* and Premal D. Lulla, MBBS1

1Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX
2Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, TX
3Department of Pediatrics, Baylor College of Medicine Texas Children's Hospital, Houston, TX
4Texas Children's Hospital/ Baylor College of Medicine, Houston, TX

12:45 PM

Chiara F Magnani1*, Giuseppe Gaipa, PhD2,3, Federico Lussana, MD4*, Giuseppe Gritti, MD, PhD4*, Daniela Belotti3,5*, Sara Napolitano, MD5*, Chiara Buracchi, PhD2*, Gian Maria Borleri4*, Benedetta Rambaldi, MD4*, Silvia Zaninelli6*, Giuliana Rizzuto4*, Gianluca Cavallaro4*, Sarah Tettamanti, PhD2*, Giovanni Cazzaniga, PhD2, Stefania Galimberti, PhD7*, Silvia Ferrari, MD4*, Martino Introna, MD4,6, Adriana Balduzzi, MD5, Maria Grazia Valsecchi, PhD7*, Giuseppe Dastoli, MD2*, Alessandro Rambaldi, MD4,8 and Andrea Biondi, MD5,9

1Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicoc, Monza, Italy
2Tettamanti Research Center, Department of Pediatrics, University of Milano - Bicocca/Fondazione MBBM, Monza, Italy
3Laboratorio di Terapia Cellulare e Genica Stefano Verri, ASST-Monza, Ospedale San Gerardo, Monza, Italy
4Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
5Department of Pediatrics, University of Milano - Bicocca, Fondazione MBBM, Monza, Italy
6USS Centro di Terapia Cellulare "G. Lanzani", Bergamo, Italy
7Bicocca Bioinformatics, Biostatistics and Bioimaging Centre B4, Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy
8Department of Oncology and Hematology, University of Milan, Milan, Italy
9Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy

1:00 PM

Junfang Yang1,2*, Xian Zhang1,2, Ying Liu3*, Xiao Yang1*, Hui Wang, MD1,2*, Lin Wang, MSc3*, Jianqiang Li, PhD3 and Peihua Lu, MD1,2,4

1Beijing Lu Daopei Institute of Hematology, Beijing, China
2Hebei Yanda Lu Daopei Hospital, Langfang, China
3Hebei Senlang Biotechnology Co., Ltd., Shijiazhuang, China
4Department of Oncology, Capital Medical University, Beijing, China

1:15 PM

Regina M. Myers, MD1, Kaitlin Devine, MD1*, Yimei Li, PhD2*, Sophie Lawrence, BS1*, Allison Barz Leahy, MD1*, Hongyan Liu, PhD3*, Lauren Vernau, BA1*, Colleen Callahan, MSN, CRNP1*, Diane Baniewicz, MSN, CRNP1*, Stephan Kadauke, MD, PhD4*, Regina McGuire, BS1*, Margaret A Cameron1*, Amanda M. DiNofia, MD, MSCE1*, Susan R. Rheingold, MD1, Richard Aplenc, MD, PhD1, Carl H June, MD5, Stephan A. Grupp, MD, PhD1, Lisa Wray, MD1* and Shannon L. Maude, MD, PhD1

1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
3Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Pathology, Children’s Hospital of Philadelphia, Philadelphia, PA
5Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA

*signifies non-member of ASH